Shanghai Orsin Medical Technology Co., Ltd.
Shanghai Orsin Medical Technology Co., Ltd.
products
Home /

products

Test Tube High Accuracy Cell Free DNA Broad Coverage Liquid Biopsy Customized

Product Details

Place of Origin: China

Brand Name: Orsin

Payment & Shipping Terms

Minimum Order Quantity: 100

Price: Negotiation

Payment Terms: L/C, D/A, D/P, T/T, Western Union

Get Best Price
Chat Now
Specifications
Highlight:

High accuracy Liquid Biopsy Test Tube

,

Broad Coverage Liquid Biopsy Test Tube

,

Cell Free DNA Liquid Biopsy Test Tube

Feature:
Customization
Capacity:
Customization
Product Name:
Cell Free DNA
Clinical Use:
Blood Bank
Characteristic:
Liquid Biopsy
Material:
Glass And Pet
Feature:
Customization
Capacity:
Customization
Product Name:
Cell Free DNA
Clinical Use:
Blood Bank
Characteristic:
Liquid Biopsy
Material:
Glass And Pet
Description
Test Tube High Accuracy Cell Free DNA Broad Coverage Liquid Biopsy Customized
Test Tube High Accuracy Cell Free DNA Broad Coverage Liquid Biopsy Customized
Product Attributes
Feature Customization
Capacity Customization
Product Name Cell Free DNA
Clinical Use Blood bank
Characteristic Liquid Biopsy
Material Glass and PET
Product Description

Accurate Volume DHA Sterile And Safe Compatible With Equipment Customization

Orsin Medical Technology's Cell-Free DNA (cfDNA) Detection System revolutionizes disease diagnosis and monitoring through cutting-edge liquid biopsy technology. Our solution delivers highly sensitive, non-invasive, and real-time genomic analysis for early cancer screening, prenatal testing, transplant monitoring, and beyond.

Key Features & Advantages:
  • Ultra-Sensitive Detection - Powered by NGS and proprietary bioinformatics, our platform detects trace cfDNA mutations with > 99% accuracy, enabling early disease identification.
  • Minimally Invasive - A simple blood draw replaces risky tissue biopsies, ensuring patient safety and comfort.
  • Multi-Application Flexibility - Covers oncology (early cancer screening, MRD monitoring), NIPT (fetal aneuploidy detection), and transplant rejection tracking.
  • Rapid & Scalable - High-throughput workflow delivers fast, reliable results, ideal for clinical and research use.
  • AI-Enhanced Analysis - Our advanced algorithms improve mutation calling, reducing false positives/negatives.
Specifications
Parameter Description/Options
Tube Cap Color Red, Lavender (Purple), Green, Gray, Blue, Yellow, Black, etc.
Additive Type None (Clot activator), EDTA, Heparin, Sodium Citrate, Sodium Fluoride, etc.
Clinical Use Serum separation, Hematology, Coagulation, Chemistry, Glucose, Blood Bank, etc.
Nominal Volume 2ml, 3ml, 4ml, 5ml, 6ml, 7ml, 8ml, 10ml, etc.
Draw Volume Range ±10% of nominal volume (e.g., 4.5-5.5ml for 5ml tube)
Tube Diameter 13mm, 16mm (standard adult size)
Tube Length 75mm, 100mm, etc.
Material PET plastic, Glass
Sterilization Gamma irradiation, EO Gas
Expiry Period Typically 12-36 months (from date of manufacture)
Common Parameters by Tube Color:
Cap Color Additive Mixing Inversion Count Clinical Applications
Red None/Clot activator 5-6 Serum chemistry, Immunology
Lavender K2/K3 EDTA 8-10× 8-10 Hematology (CBC, Blood Smear)
Green Lithium Heparin 8-10× 8-10 Plasma chemistry, STAT tests
Gray NaF/K Oxalate 8-10× 8-10 Glucose tolerance, Alcohol tests
Blue Sodium Citrate 3-4× 3-4 Coagulation tests (PT, APTT)
Applications
1. Hospital Routine Testing

Scenario: Blood tests for routine diagnostics (CBC, biochemistry, coagulation) in outpatient/inpatient settings.

Adaptability:

  • Accurate Volume Control (±5% tolerance) ensures consistent results and reduces retesting rates.
  • Multiple additives (EDTA, heparin, sodium citrate) tailored for diverse testing requirements.
  • Compatibility with automated analyzers (e.g., Roche, Siemens, Abbott) and seamless integration with hospital LIS/HIS systems.
2. Emergency & Critical Care

Scenario: Rapid analysis of blood gases, electrolytes, and cardiac markers (e.g., troponin) in urgent care.

Adaptability:

  • DHA (Dual Hemostasis Activator) Technology accelerates blood separation, reducing preprocessing time (<15 minutes).
  • Gray-top tubes (sodium fluoride/potassium oxalate) prevent glucose degradation for accurate emergency glucose testing.
3. Research & Laboratory Studies

Scenario: Genomics (DNA/RNA extraction), proteomics, and drug metabolism research.

Adaptability:

  • Sterile, non-pyrogenic design eliminates exogenous contamination, ideal for high-sensitivity assays (e.g., PCR, ELISA).
  • Customization options: additive-free tubes, low-adsorption tubes, or pre-filled specialty anticoagulants (e.g., CPDA-1).
4. Blood Banking & Transfusion Medicine

Scenario: Blood component separation (plasma, RBCs, platelets), blood typing, and cross-matching.

Adaptability:

  • Blue-top sodium citrate tubes (3.2% concentration) comply with international coagulation standards (CLSI H21-A5).
  • High-strength PET material ensures leak-proof integrity for safe cold-chain transport.
5. Pediatrics & Special Populations

Scenario: Low-volume collection for neonates or patients with fragile veins.

Adaptability:

  • Custom small-volume tubes (1-2ml) minimize blood draw, with color-coded caps (pink/yellow) for easy identification.
  • Smooth inner walls reduce hemolysis risk, compatible with fine needles (≤25G).
6. Epidemiology & Public Health

Scenario: Large-scale screening (e.g., HIV, hepatitis, metabolic syndrome).

Adaptability:

  • Batch-customized tubes with pre-printed barcodes/QR codes enable rapid sample tracking.
  • High-temperature-resistant glass tubes (optional) for processing infectious samples.
7. Telemedicine & POCT (Point-of-Care Testing)

Scenario: Community clinics, home healthcare, and remote area testing.

Adaptability:

  • Gel-separator tubes (orange cap) stabilize plasma/serum for up to 72 hours at 25°C.
  • Lightweight design compatible with portable centrifuges and POCT devices (e.g., i-STAT).
Why Choose Orsin's cfDNA Solution?
  • Clinically Validated - Trusted by leading hospitals and labs.
  • Cost-Effective - Reduces unnecessary invasive procedures and long hospital stays.
  • Orsin Medical Technology empowers precision medicine with smarter, safer, and faster cfDNA diagnostics. Early detection. Better outcomes.
  • Future-Ready - Continuously optimized for emerging biomarkers (methylation, fragmentomics).
Send your inquiry
Please send us your request and we will reply to you as soon as possible.
Send